Last reviewed · How we verify

US-guided tenotomy with PRP — Competitive Intelligence Brief

US-guided tenotomy with PRP (US-guided tenotomy with PRP) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Orthopedics.

phase 3 Orthopedics Small molecule Live · refreshed every 30 min

Target snapshot

US-guided tenotomy with PRP (US-guided tenotomy with PRP) — Jose Ignacio Martin. US-guided tenotomy with PRP is a minimally invasive procedure that uses ultrasound guidance to release tension in tendons and ligaments, with the addition of platelet-rich plasma (PRP) to promote healing.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
US-guided tenotomy with PRP TARGET US-guided tenotomy with PRP Jose Ignacio Martin phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). US-guided tenotomy with PRP — Competitive Intelligence Brief. https://druglandscape.com/ci/us-guided-tenotomy-with-prp. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing